Skip to main content
. 2015 Sep 15;8(4):190–192. doi: 10.1177/1753495X15598909

Table 2.

Case repots of methyldopa associated liver failure.

Case report Maternal age (years) GA at which methyldopa initiated (weeks) GA at symptom onset (weeks) Symptoms Outcome
Picaud et al.5 *Abstract only 22 33 3rd trimester Initial symptoms of nausea, vomiting, and increased temperature; associated with febrile jaundice and coagulopathy in the third stage of labor. Patient passed away 3 days after delivery due to hematemesis, renal failure, and hepatic encephalopathy. Maternal death 3 days after delivery
Smith and Piercy6 30 10 13 Jaundice, abdominal pain, nausea Methyldopa discontinued at 14 weeks and re-introduced at 36 weeks’ gestation; C-section for family planning
Thomas and Cardwell7 37 6 15 Jaundice, dark urine Complete resolution of symptoms at 21 weeks with discontinuation of medication
Phadis et al.12 40 6 8 Jaundice, dark urine, myalgia, fatigue, fever Switched to labetalol and liver function gradually improved between 10 and24 weeks
Ali et al.8 33 6 12 Jaundice, dark urine Resolved 2 weeks later with a course of prednisone
Ozsvar et al.9 35 21 23 Transaminitis Switched to nifedipine; no information on outcome
Slim et al.10 34 13 17 Jaundice, pruritus, dark urine, pale stool Liver function test results returned to normal levels within 5 weeks of discontinuation

GA: gestational age.